Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-30 @ 3:54 PM
Study NCT ID:
NCT05562934
Status:
COMPLETED
Last Update Posted:
2025-10-24
First Post:
2022-09-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2022-09-28
First Submit QC Date:
None
Study First Post Date:
2022-10-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-26
Results First Submit QC Date:
None
Results First Post Date:
2025-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-10-24
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED